CC
The Chemours Company NYSE Listed Jun 19, 2015$22.40
Mkt Cap $3.4B
52w Low $9.13
67.9% of range
52w High $28.67
50d MA $21.38
200d MA $16.14
P/E (TTM)
-10.8x
EV/EBITDA
17.1x
P/B
16.6x
Debt/Equity
18.3x
ROE
-18.8%
P/FCF
34.8x
RSI (14)
—
ATR (14)
—
Beta
1.40
50d MA
$21.38
200d MA
$16.14
Avg Volume
3.4M
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
1007 Market Street · Wilmington, DE 19899 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | -0.05 | -0.19 | -280.0% | 27.94 | -9.8% | -15.3% | -19.8% | — | — | — | — |
| Feb 19, 2026 | AMC | 0.09 | 0.05 | -43.6% | 20.41 | -8.7% | -16.5% | -11.7% | -9.8% | -11.7% | -15.1% | — |
| Nov 6, 2025 | AMC | 0.24 | 0.20 | -16.7% | 11.74 | -3.1% | +6.6% | +8.6% | +7.8% | +7.4% | +4.5% | — |
| Aug 5, 2025 | AMC | 0.46 | 0.58 | +26.1% | 12.63 | +4.7% | -5.0% | -3.6% | -3.5% | -7.5% | -1.7% | — |
| May 6, 2025 | AMC | 0.19 | 0.13 | -31.6% | 12.10 | -14.7% | -9.9% | -7.1% | -8.6% | -0.9% | -2.6% | — |
| Feb 18, 2025 | AMC | 0.10 | 0.11 | +10.0% | 17.48 | -4.3% | -1.8% | +0.0% | -4.1% | -7.6% | -9.6% | — |
| Nov 4, 2024 | AMC | 0.32 | 0.40 | +25.0% | 20.58 | -2.1% | -3.4% | +0.7% | -0.6% | -3.8% | -3.7% | — |
| Aug 1, 2024 | AMC | 0.57 | 0.38 | -33.3% | 23.31 | -13.8% | -11.9% | -19.6% | -19.7% | -23.5% | -21.7% | — |
| Apr 30, 2024 | AMC | 0.18 | 0.32 | +77.8% | 26.75 | -0.5% | -2.8% | -2.2% | -0.7% | +2.3% | +4.6% | — |
| Mar 27, 2024 | AMC | 0.29 | 0.31 | +6.9% | 28.88 | -13.4% | -9.1% | -0.5% | -4.4% | -0.5% | -5.5% | — |
| Oct 26, 2023 | AMC | 0.77 | 0.64 | -16.9% | 24.24 | -1.1% | -2.7% | +2.0% | -0.5% | -1.2% | +0.8% | — |
| Jul 27, 2023 | AMC | 1.09 | 1.10 | +0.9% | 37.95 | -1.4% | -3.6% | -2.6% | -2.9% | -3.5% | -3.6% | — |
| Apr 27, 2023 | AMC | 0.47 | 0.98 | +108.5% | 27.95 | -1.1% | +4.0% | +6.5% | +8.6% | +4.4% | +2.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 | Truist | Maintains | Buy → Buy | — | $26.48 | $26.58 | +0.4% | -2.9% | -0.5% | +1.8% | +4.7% | +2.8% |
| Apr 9 | UBS | Maintains | Buy → Buy | — | $21.43 | $21.34 | -0.4% | +1.9% | +6.0% | +7.6% | +6.8% | +7.5% |
| Apr 9 | Truist | Maintains | Buy → Buy | — | $21.43 | $21.34 | -0.4% | +1.9% | +6.0% | +7.6% | +6.8% | +7.5% |
| Mar 5 | Mizuho | Maintains | Outperform → Outperform | — | $17.53 | $17.71 | +1.0% | -4.4% | -6.4% | -0.6% | +1.5% | +2.1% |
| Feb 25 | Goldman Sachs | Maintains | Neutral → Neutral | — | $18.41 | $18.59 | +1.0% | -2.1% | -5.9% | -0.9% | -2.3% | -8.9% |
| Feb 23 | UBS | Maintains | Buy → Buy | — | $17.04 | $16.81 | -1.3% | +5.8% | +8.0% | +5.8% | +1.6% | +7.0% |
| Feb 23 | BMO Capital | Maintains | Outperform → Outperform | — | $17.04 | $16.81 | -1.3% | +5.8% | +8.0% | +5.8% | +1.6% | +7.0% |
| Feb 23 | JP Morgan | Maintains | Neutral → Neutral | — | $17.04 | $16.81 | -1.3% | +5.8% | +8.0% | +5.8% | +1.6% | +7.0% |
| Feb 23 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $17.04 | $16.81 | -1.3% | +5.8% | +8.0% | +5.8% | +1.6% | +7.0% |
| Jan 21 | Truist | Maintains | Buy → Buy | — | $15.26 | $15.84 | +3.8% | +6.1% | +5.1% | +3.2% | +3.5% | +2.4% |
| Dec 3 | JP Morgan | Maintains | Neutral → Neutral | — | $12.77 | $12.71 | -0.5% | +1.5% | -1.8% | -0.5% | -4.5% | -2.9% |
| Nov 11 | UBS | Maintains | Buy → Buy | — | $12.75 | $12.75 | +0.0% | -0.8% | -1.1% | -3.8% | -6.7% | -11.8% |
| Nov 10 | RBC Capital | Maintains | Outperform → Outperform | — | $12.51 | $12.62 | +0.9% | +1.9% | +1.1% | +0.8% | -1.9% | -5.0% |
| Nov 10 | Truist | Maintains | Buy → Buy | — | $12.51 | $12.62 | +0.9% | +1.9% | +1.1% | +0.8% | -1.9% | -5.0% |
| Oct 16 | Mizuho | Maintains | Outperform → Outperform | — | $14.42 | $14.29 | -0.9% | -4.6% | -10.5% | -7.7% | -7.4% | -6.2% |
| Oct 6 | UBS | Maintains | Buy → Buy | — | $16.13 | $16.40 | +1.7% | -2.0% | -6.4% | -6.8% | -14.8% | -22.2% |
| Sep 23 | Mizuho | Maintains | Outperform → Outperform | — | $17.02 | $17.21 | +1.1% | -3.1% | -3.9% | -9.9% | -8.0% | -8.3% |
| Sep 16 | Truist | Maintains | Buy → Buy | — | $17.26 | $17.34 | +0.5% | -1.0% | -0.5% | +1.6% | -1.4% | -1.4% |
| Jul 15 | Mizuho | Maintains | Outperform → Outperform | — | $13.49 | $13.73 | +1.8% | -2.4% | -1.8% | +1.3% | +0.5% | +0.6% |
| Jul 3 | RBC Capital | Maintains | Outperform → Outperform | — | $12.73 | $13.02 | +2.3% | +1.6% | -2.4% | +7.1% | +8.2% | +10.4% |
| May 28 | Barclays | Maintains | Equal Weight → Equal Weight | — | $10.62 | $10.57 | -0.5% | -5.7% | -4.8% | -4.6% | -11.5% | -6.5% |
| May 14 | Goldman Sachs | Maintains | Neutral → Neutral | — | $11.78 | $11.63 | -1.3% | -3.1% | -6.3% | -5.2% | -5.1% | -5.2% |
| May 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $11.06 | $11.68 | +5.6% | +8.4% | +6.5% | +3.3% | -0.2% | +1.0% |
| May 8 | RBC Capital | Maintains | Outperform → Outperform | — | $10.90 | $11.18 | +2.6% | +3.1% | +1.5% | +10.0% | +8.1% | +4.8% |
| May 7 | UBS | Maintains | Buy → Buy | — | $12.10 | $10.32 | -14.7% | -9.9% | -7.1% | -8.6% | -0.9% | -2.6% |
| Apr 14 | Truist | Maintains | Buy → Buy | — | $11.28 | $11.62 | +3.0% | +2.1% | -1.5% | -2.3% | +0.7% | +0.4% |
| Apr 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $13.53 | $13.25 | -2.1% | -4.2% | -3.5% | -15.6% | -21.5% | -22.2% |
| Mar 27 | Mizuho | Upgrade | Neutral → Outperform | — | $13.83 | $14.11 | +2.0% | +3.3% | -0.8% | -2.2% | -6.3% | -5.6% |
| Feb 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.76 | $16.71 | -0.3% | -3.6% | -5.7% | -4.5% | -9.3% | -10.8% |
| Feb 19 | BMO Capital | Maintains | Outperform → Outperform | — | $17.48 | $16.72 | -4.3% | -1.8% | +0.0% | -4.1% | -7.6% | -9.6% |
| Jan 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $17.64 | $17.66 | +0.1% | +4.2% | +5.6% | +6.5% | +8.2% | +10.0% |
| Jan 7 | Mizuho | Maintains | Neutral → Neutral | — | $16.93 | $17.44 | +3.0% | +10.8% | +5.7% | +4.2% | +8.6% | +10.0% |
| Jan 7 | Goldman Sachs | Maintains | Neutral → Neutral | — | $16.93 | $17.44 | +3.0% | +10.8% | +5.7% | +4.2% | +8.6% | +10.0% |
| Dec 12 | RBC Capital | Maintains | Outperform → Outperform | — | $19.42 | $19.40 | -0.1% | -0.1% | -2.0% | -3.4% | -6.2% | -10.6% |
| Nov 6 | RBC Capital | Maintains | Outperform → Outperform | — | $19.88 | $20.58 | +3.5% | +4.2% | +2.9% | -0.5% | -0.4% | -2.9% |
| Nov 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $20.58 | $20.14 | -2.1% | -3.4% | +0.7% | -0.6% | -3.8% | -3.7% |
| Nov 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $20.58 | $20.14 | -2.1% | -3.4% | +0.7% | -0.6% | -3.8% | -3.7% |
| Oct 11 | RBC Capital | Maintains | Outperform → Outperform | — | $19.78 | $19.70 | -0.4% | +3.0% | +0.9% | -1.4% | +0.4% | -0.1% |
| Oct 7 | BMO Capital | Maintains | Outperform → Outperform | — | $19.57 | $19.85 | +1.4% | +2.6% | -0.2% | +0.5% | +1.1% | +4.1% |
| Sep 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $19.55 | $19.47 | -0.4% | -4.4% | +6.4% | +6.0% | +3.9% | +0.8% |
| Sep 3 | Goldman Sachs | Maintains | Neutral → Neutral | — | $19.44 | $18.92 | -2.7% | -4.2% | -4.7% | -4.8% | -10.1% | -12.0% |
| Aug 6 | UBS | Maintains | Buy → Buy | — | $18.75 | $18.75 | +0.0% | -0.2% | -4.9% | -2.6% | -3.4% | -4.7% |
| Aug 6 | BMO Capital | Maintains | Outperform → Outperform | — | $18.75 | $18.75 | +0.0% | -0.2% | -4.9% | -2.6% | -3.4% | -4.7% |
| Aug 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.75 | $18.75 | +0.0% | -0.2% | -4.9% | -2.6% | -3.4% | -4.7% |
| Aug 6 | JP Morgan | Maintains | Neutral → Neutral | — | $18.75 | $18.75 | +0.0% | -0.2% | -4.9% | -2.6% | -3.4% | -4.7% |
| Jul 9 | UBS | Upgrade | Neutral → Buy | — | $22.32 | $23.46 | +5.1% | +0.6% | +3.8% | +8.7% | +9.8% | +11.7% |
| Apr 9 | BMO Capital | Upgrade | Market Perform → Outperform | — | $27.05 | $28.00 | +3.5% | +4.1% | +1.7% | +0.9% | -2.1% | -3.8% |
| Apr 2 | UBS | Maintains | Neutral → Neutral | — | $28.74 | $28.19 | -1.9% | -3.9% | -0.0% | -5.0% | -6.0% | -5.9% |
| Apr 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $28.74 | $28.19 | -1.9% | -3.9% | -0.0% | -5.0% | -6.0% | -5.9% |
| Mar 5 | UBS | Downgrade | Buy → Neutral | — | $20.19 | $19.75 | -2.2% | +1.6% | +9.1% | +25.6% | +28.0% | +29.4% |
No insider trades available.
8-K · 5.02
!!! Very High
The Chemours Company -- 8-K 5.02: Executive Change
Apr 30
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
CC secured new financing through Deutsche Bank, providing capital flexibility that could fund operations or acquisitions, though investors should monitor debt terms and repayment obligations that affect future profitability.
Mar 12
8-K · 8.01
!! High
The Chemours Company -- 8-K 8.01: Material Event / Announcement
Chemours increased its senior unsecured debt offering to $700 million from $600 million, raising additional capital through 7.875% notes maturing in 2034.
Feb 26
8-K
The Chemours Company -- 8-K Filing
Chemours prioritized cash flow over earnings in its Advanced Performance Materials division, resulting in inventory charges and unfavorable product mix that slightly missed adjusted EBITDA guidance despite strong cash generation.
Feb 19
Data updated apr 25, 2026 12:12am
· Source: massive.com